Richardson Capital Management’s AstraZeneca AZN Stock Holding History

Richardson Capital Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15	Closed	-$2.96K	–	258
2026 Q1	$2.96K	Buy	+15	New	+$2.89K	﹤0.01%	323
2024 Q3	–	Sell	-32	Closed	-$4.99K	–	145
2024 Q2	$4.99K	Buy	+32	New	+$4.82K	﹤0.01%	141

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Richardson Capital Management's AZN Position: Q2 2026 in Review

Richardson Capital Management sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 15 shares — an estimated $2.96K sold.

Richardson Capital Management first reported a position in AZN in Q2 2024 and held it in 2 quarters. The position peaked at $4.99K in Q2 2024. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Richardson Capital Management reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
Richardson Capital Management sold 15 AstraZeneca shares in Q2 2026, an estimated $2.96K.
Richardson Capital Management first reported a position in AstraZeneca in Q2 2024 and held it in 2 quarters.
Richardson Capital Management's AstraZeneca position peaked at $4.99K in Q2 2024.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Richardson Capital Management's 13F filing for Q2 2026, filed 17 Jul 2026.